WO2002051354A3 - Systeme et procede d'elaboration de medicaments destines a une utilisation selective de medicaments chez des individus, patients repondant au traitement et applications du procede dans des soins medicaux - Google Patents

Systeme et procede d'elaboration de medicaments destines a une utilisation selective de medicaments chez des individus, patients repondant au traitement et applications du procede dans des soins medicaux Download PDF

Info

Publication number
WO2002051354A3
WO2002051354A3 PCT/US2001/049457 US0149457W WO02051354A3 WO 2002051354 A3 WO2002051354 A3 WO 2002051354A3 US 0149457 W US0149457 W US 0149457W WO 02051354 A3 WO02051354 A3 WO 02051354A3
Authority
WO
WIPO (PCT)
Prior art keywords
medical
studies
care
criteria
safety
Prior art date
Application number
PCT/US2001/049457
Other languages
English (en)
Other versions
WO2002051354A2 (fr
Inventor
Robert E Becker
Original Assignee
Robert E Becker
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert E Becker filed Critical Robert E Becker
Priority to AU2002239664A priority Critical patent/AU2002239664A1/en
Publication of WO2002051354A2 publication Critical patent/WO2002051354A2/fr
Publication of WO2002051354A3 publication Critical patent/WO2002051354A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computed tomography [CT]
    • A61B6/032—Transmission computed tomography [CT]
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00—ICT specially adapted for the handling or processing of medical images
    • G16H30/40—ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Biomedical Technology (AREA)
  • Theoretical Computer Science (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Optics & Photonics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne un système et un procédé destinés à des chercheurs médicaux effectuant des recherches au niveau d'une procédure ou d'une intervention médicamenteuse, ou de l'efficacité, la sécurité, l'aspect économique ou l'utilisation d'un dispositif, aux fins de développement et de test d'un modèle de décision déterminant de manière individuelle pour chaque patient l'efficacité, la sécurité, les avantages économiques et l'utilisation probables de médicaments ou de dispositifs médicaux. Le modèle met en oeuvre des études permettant de déterminer la fiabilité des mesures, du critère de signification clinique, du critère de signification statistique, des études de la validité interne d'évaluations de patient placé aussi bien dans des conditions régulées de placebo en double aveugle que dans des conditions régulées de non placebo non en double aveugle. L'invention concerne également des procédés permettant de confirmer les prévisions du modèle d'essai clinique et des études de prévisions à long terme de statut salutaire, à partir de mesures de résultat, ainsi que d'essais cliniques ou d'autres conceptions de recherche médicale permettant d'identifier la réponse de chaque individu au traitement. Le modèle de décision permet d'améliorer la mise en oeuvre de normes scientifiques et médicales de soins médicaux de patients dans un cabinet médical et peut être appliqué dans des soins médicaux, l'élaboration et la régulation de médicament, le financement de soins médicaux, des dossiers médicaux électroniques et dans une officine pharmaceutique.
PCT/US2001/049457 2000-12-26 2001-10-26 Systeme et procede d'elaboration de medicaments destines a une utilisation selective de medicaments chez des individus, patients repondant au traitement et applications du procede dans des soins medicaux WO2002051354A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002239664A AU2002239664A1 (en) 2000-12-26 2001-10-26 Method for drug development using individual patient response

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US25826200P 2000-12-26 2000-12-26
US60/258,262 2000-12-26
US27498101P 2001-03-12 2001-03-12
US60/274,981 2001-03-12
US30152601P 2001-06-28 2001-06-28
US60/301,526 2001-06-28

Publications (2)

Publication Number Publication Date
WO2002051354A2 WO2002051354A2 (fr) 2002-07-04
WO2002051354A3 true WO2002051354A3 (fr) 2003-02-27

Family

ID=27401126

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/049457 WO2002051354A2 (fr) 2000-12-26 2001-10-26 Systeme et procede d'elaboration de medicaments destines a une utilisation selective de medicaments chez des individus, patients repondant au traitement et applications du procede dans des soins medicaux

Country Status (2)

Country Link
AU (1) AU2002239664A1 (fr)
WO (1) WO2002051354A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003269395A1 (en) 2002-09-16 2004-04-30 Optimata, Ltd. An interactive technique for optimizing drug development from the pre-clinical phases through phase-iv
US8489336B2 (en) 2002-09-16 2013-07-16 Optimata Ltd. Techniques for purposing a new compound and for re-purposing a drug
AU2002952938A0 (en) * 2002-11-27 2002-12-12 Ilifedata Pty Ltd System for Conducting Clinical Trials
WO2006050980A2 (fr) * 2004-11-15 2006-05-18 Novo Nordisk A/S Procede et appareil permettant de surveiller des effets a long et court termes d'un traitement
CA2623955C (fr) 2005-09-23 2019-12-17 Acorda Therapeutics, Inc. Procede, appareil et logiciel d'identification de sujets repondants dans un environnement clinique
AU2013206188B2 (en) * 2005-09-23 2016-04-14 Acorda Therapeutics, Inc. Method, apparatus and software for identifying responders in a clinical environment
US9092566B2 (en) 2012-04-20 2015-07-28 International Drug Development Institute Methods for central monitoring of research trials
US10123729B2 (en) 2014-06-13 2018-11-13 Nanthealth, Inc. Alarm fatigue management systems and methods
US10437959B2 (en) 2014-08-28 2019-10-08 Nanthealth, Inc. Patient sensor data exchange systems and methods
US20200395103A1 (en) * 2018-02-21 2020-12-17 Klaritos, Inc. Methods of performing clinical trials
US11093883B2 (en) * 2018-08-03 2021-08-17 Camelot Uk Bidco Limited Apparatus, method, and computer-readable medium for determining a drug for manufacture
CN116580797B (zh) * 2023-05-15 2023-10-31 北京利久医药科技有限公司 一种临床试验数据的快速比对方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LARSON E.B. ET AL.: "Randomized clinical trials in single patients during a 2-year period", JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, vol. 270, no. 22, 8 December 1993 (1993-12-08), pages 2708 - 2712, XP002952323 *
ZUCKER D.R. ET AL.: "Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment", JOURNAL OF CLINICAL EPIDEMIOLOGY, vol. 50, no. 4, 1997, pages 401 - 410, XP002952324 *

Also Published As

Publication number Publication date
AU2002239664A1 (en) 2002-07-08
WO2002051354A2 (fr) 2002-07-04

Similar Documents

Publication Publication Date Title
CA2334408A1 (fr) Appareil et technique visant a soulager la douleur et a diminuer l'anxiete associees a des interventions medicales ou chirurgicales chez un patient conscient
US20020091308A1 (en) Method and apparatus for the synchronized therapeutic treatment of a life form
Moreno Ethnomusic therapy: An interdisciplinary approach to music and healing.
WO2002051354A3 (fr) Systeme et procede d'elaboration de medicaments destines a une utilisation selective de medicaments chez des individus, patients repondant au traitement et applications du procede dans des soins medicaux
WO2002019247A3 (fr) Système d'analyse et de recherche relatives à des patients, méthodes afférentes
WO2005083621A8 (fr) Systeme et procede de gestion d'une therapie avancee utilisant des medicaments pour patients
Oliver et al. The treatment of severe self-injurious behavior by the systematic fading of restraints: Effects on self-injury, self-restraint, adaptive behavior, and behavioral correlates of affect
Moline Patient psychologic preparation for invasive procedures: an integrative review
Areán et al. The treatment of depression in elderly primary care patients: A naturalistic study.
WO2002099600A3 (fr) Methode et systeme pour ameliorer les systemes vasculaires par feed-back biologique et reseautage
Milnes Intravenous procedural sedation: an alternative to general anesthesia in the treatment of early childhood caries
Bowes The doctor as patient: an encounter with Guillain-Bárré syndrome.
Lipkin The care of patients: Perspectives and practices, Rev
Kaloupek Recommendations for psychological intervention with patients undergoing invasive medical procedures.
CN2645660Y (zh) 人体周身毛孔呼吸气道充输药磁排毒装置
Lefrak et al. Nursing practise in the neonatal intensive care unit
Poole et al. Patients who request alternative (nonmedical) health care.
CN2882673Y (zh) 治疗脑神经疾病的磁疗装置
Chan et al. Etomidate and midazolam for procedural sedation in the emergency department of Queen Elizabeth Hospital: a randomised controlled trial
Beech The Role of Acupuncture in Radiotherapy‐Induced Xerostomia
Kim Development of a critical pathway for patients with coronary artery bypass graft
Burns et al. Organizing psychiatric care in general hospitals to meet medical and psychiatric needs.
Namerow Current concepts and advances in brain injury rehabilitation
Buyruk et al. Acute Medical Rehabilitation in Intensive Care
Brewer " Correlates of alcohol use among methadone patients": Comment.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 10182785

Country of ref document: US

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP